ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer
Titel:
ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer
Auteur:
Ozturk, Harun Cingoz, Harun Tufan, Turan Yang, Jiekun Adair, Sara J. Tummala, Krishna Seshu Kuscu, Cem Kinali, Meric Comertpay, Gamze Nagdas, Sarbajeet Goudreau, Bernadette J. Luleyap, Husnu Umit Bingul, Yagmur Ware, Timothy B. Hwang, William L. Hsu, Ku-lung Kashatus, David F. Ting, David T. Chandel, Navdeep S. Bardeesy, Nabeel Bauer, Todd W. Adli, Mazhar